|Project Title||Anticoagulant Use Among Members with Atrial Fibrillation and Various Pre-Existing Exlusions|
Friday, May 27, 2016
Modular program-based one-time assessment of the use of two anticoagulants, warfarin and dabigatran, among members with a pre-existing condition of atrial fibrillation and various pre-existing exclusions, including chronic liver disease, hypercholesterolemia, malignancy, coronary revascularization, other ischemic heart disease, cerebral revascularization, urinary incontinence, TIA, other cerebrovascular disease, hospitalized pneumonia, cardioversion, cardioablation, estrogen replacement, H2 antagonists, nitrates, statins, fibrates, antifungals, verapamil. The query was run against the Mini-Sentinel Distributed Database (MSDD) for the time period of October 19, 2010 to December 31, 2012. Modular programs are adaptable standardized programs. Results were generated using Modular Program 3, version 1.0; click here for more information. Queries were distributed in November 2013. This report includes data from 18 Data Partners.
|Population / Cohort|
All individuals with atrial fibrillation and exclusions
October 19, 2010 - December 31, 2012
Mini-Sentinel Distributed Database (MSDD)